CN104491529A - Traditional Chinese medicine granule for treating II diabetes and preparation method thereof - Google Patents
Traditional Chinese medicine granule for treating II diabetes and preparation method thereof Download PDFInfo
- Publication number
- CN104491529A CN104491529A CN201410772168.4A CN201410772168A CN104491529A CN 104491529 A CN104491529 A CN 104491529A CN 201410772168 A CN201410772168 A CN 201410772168A CN 104491529 A CN104491529 A CN 104491529A
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- chinese medicine
- diabetes
- herba
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 88
- 239000008187 granular material Substances 0.000 title claims abstract description 61
- 238000002360 preparation method Methods 0.000 title claims description 25
- 206010012601 diabetes mellitus Diseases 0.000 title abstract description 16
- 240000007594 Oryza sativa Species 0.000 claims abstract description 38
- 235000007164 Oryza sativa Nutrition 0.000 claims abstract description 38
- 210000000582 semen Anatomy 0.000 claims abstract description 24
- 235000009566 rice Nutrition 0.000 claims abstract description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 52
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims description 41
- 241000218236 Cannabis Species 0.000 claims description 20
- 238000009835 boiling Methods 0.000 claims description 18
- 229940079593 drug Drugs 0.000 claims description 17
- 238000003756 stirring Methods 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 13
- 238000004659 sterilization and disinfection Methods 0.000 claims description 13
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 11
- 206010013786 Dry skin Diseases 0.000 claims description 7
- 238000004140 cleaning Methods 0.000 claims description 7
- 238000001035 drying Methods 0.000 claims description 7
- 239000007788 liquid Substances 0.000 claims description 7
- 239000000155 melt Substances 0.000 claims description 7
- 238000005507 spraying Methods 0.000 claims description 7
- 239000000052 vinegar Substances 0.000 claims description 7
- 235000021419 vinegar Nutrition 0.000 claims description 7
- 241000209094 Oryza Species 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 22
- 210000004369 blood Anatomy 0.000 abstract description 22
- 230000000694 effects Effects 0.000 abstract description 14
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 11
- 239000008103 glucose Substances 0.000 abstract description 11
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 7
- 201000010099 disease Diseases 0.000 abstract description 6
- 244000248557 Ophiopogon japonicus Species 0.000 abstract description 4
- 210000003734 kidney Anatomy 0.000 abstract description 4
- 231100000957 no side effect Toxicity 0.000 abstract description 4
- 210000002683 foot Anatomy 0.000 abstract description 3
- 230000001105 regulatory effect Effects 0.000 abstract description 3
- 240000007087 Apium graveolens Species 0.000 abstract description 2
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 abstract description 2
- 235000010591 Appio Nutrition 0.000 abstract description 2
- 241000721690 Lythrum salicaria Species 0.000 abstract description 2
- 235000003140 Panax quinquefolius Nutrition 0.000 abstract description 2
- 210000004556 brain Anatomy 0.000 abstract description 2
- 210000001508 eye Anatomy 0.000 abstract description 2
- 210000002216 heart Anatomy 0.000 abstract description 2
- 241001213442 Bohadschia marmorata Species 0.000 abstract 1
- 241000112528 Ligusticum striatum Species 0.000 abstract 1
- 235000003283 Pachira macrocarpa Nutrition 0.000 abstract 1
- 244000236658 Paeonia lactiflora Species 0.000 abstract 1
- 240000005373 Panax quinquefolius Species 0.000 abstract 1
- 244000088415 Raphanus sativus Species 0.000 abstract 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 abstract 1
- 240000001085 Trapa natans Species 0.000 abstract 1
- 235000014364 Trapa natans Nutrition 0.000 abstract 1
- 239000008186 active pharmaceutical agent Substances 0.000 abstract 1
- 240000004308 marijuana Species 0.000 abstract 1
- 235000009165 saligot Nutrition 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 19
- 239000000203 mixture Substances 0.000 description 16
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 14
- 235000009508 confectionery Nutrition 0.000 description 11
- 230000006870 function Effects 0.000 description 10
- 210000004072 lung Anatomy 0.000 description 10
- 210000002784 stomach Anatomy 0.000 description 10
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 8
- 230000007812 deficiency Effects 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 8
- 210000000952 spleen Anatomy 0.000 description 8
- 230000035922 thirst Effects 0.000 description 8
- 206010011224 Cough Diseases 0.000 description 7
- 229940125396 insulin Drugs 0.000 description 7
- 208000004880 Polyuria Diseases 0.000 description 6
- 230000036528 appetite Effects 0.000 description 6
- 235000019789 appetite Nutrition 0.000 description 6
- 206010036067 polydipsia Diseases 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 5
- 208000001848 dysentery Diseases 0.000 description 5
- 206010025482 malaise Diseases 0.000 description 5
- 230000027939 micturition Effects 0.000 description 5
- 208000026435 phlegm Diseases 0.000 description 5
- 230000001737 promoting effect Effects 0.000 description 5
- 239000003440 toxic substance Substances 0.000 description 5
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Chinese gallotannin Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 4
- 208000019255 Menstrual disease Diseases 0.000 description 4
- 210000001015 abdomen Anatomy 0.000 description 4
- 208000004104 gestational diabetes Diseases 0.000 description 4
- 231100000614 poison Toxicity 0.000 description 4
- 208000011580 syndromic disease Diseases 0.000 description 4
- PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical compound [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 3
- 201000000736 Amenorrhea Diseases 0.000 description 3
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000196324 Embryophyta Species 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 229940024606 amino acid Drugs 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 206010003549 asthenia Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 208000002173 dizziness Diseases 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 210000000936 intestine Anatomy 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- 230000000144 pharmacologic effect Effects 0.000 description 3
- 238000010791 quenching Methods 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 230000001225 therapeutic effect Effects 0.000 description 3
- 239000011701 zinc Substances 0.000 description 3
- 229910052725 zinc Inorganic materials 0.000 description 3
- XWMMEBCFHUKHEX-MRTCRTFGSA-N (+)-Taraxasterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@H]2[C@@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C XWMMEBCFHUKHEX-MRTCRTFGSA-N 0.000 description 2
- QMKPCZNFLUQTJZ-UHFFFAOYSA-N (4aR)-10c-Hydroxy-1t.2c.4ar.6at.6bc.9.9.12ac-octamethyl-(8atH.12btH.14acH.14btH)-docosahydro-picen Natural products CC1CCC2(C)CCC3(C)C(CCC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C QMKPCZNFLUQTJZ-UHFFFAOYSA-N 0.000 description 2
- WXTMDXOMEHJXQO-UHFFFAOYSA-N 2,5-dihydroxybenzoic acid Chemical compound OC(=O)C1=CC(O)=CC=C1O WXTMDXOMEHJXQO-UHFFFAOYSA-N 0.000 description 2
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 206010000077 Abdominal mass Diseases 0.000 description 2
- 208000006400 Arbovirus Encephalitis Diseases 0.000 description 2
- 208000023275 Autoimmune disease Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- 244000025254 Cannabis sativa Species 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 208000005171 Dysmenorrhea Diseases 0.000 description 2
- 206010013935 Dysmenorrhoea Diseases 0.000 description 2
- 206010052369 Encephalitis lethargica Diseases 0.000 description 2
- 201000005569 Gout Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 239000009636 Huang Qi Substances 0.000 description 2
- 206010020710 Hyperphagia Diseases 0.000 description 2
- 206010020772 Hypertension Diseases 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- WWNNZCOKKKDOPX-UHFFFAOYSA-N N-methylnicotinate Chemical compound C[N+]1=CC=CC(C([O-])=O)=C1 WWNNZCOKKKDOPX-UHFFFAOYSA-N 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 206010067171 Regurgitation Diseases 0.000 description 2
- 208000025747 Rheumatic disease Diseases 0.000 description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 2
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 229930182558 Sterol Natural products 0.000 description 2
- 206010042674 Swelling Diseases 0.000 description 2
- LSQXNMXDFRRDSJ-UHFFFAOYSA-N Thymol methyl ether Chemical compound COC1=CC(C)=CC=C1C(C)C LSQXNMXDFRRDSJ-UHFFFAOYSA-N 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010047513 Vision blurred Diseases 0.000 description 2
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 2
- 208000000260 Warts Diseases 0.000 description 2
- 206010052428 Wound Diseases 0.000 description 2
- 238000013475 authorization Methods 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 208000002894 beriberi Diseases 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 239000003651 drinking water Substances 0.000 description 2
- 235000020188 drinking water Nutrition 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 208000035861 hematochezia Diseases 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- AMWRITDGCCNYAT-UHFFFAOYSA-L hydroxy(oxo)manganese;manganese Chemical compound [Mn].O[Mn]=O.O[Mn]=O AMWRITDGCCNYAT-UHFFFAOYSA-L 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- BTNMPGBKDVTSJY-UHFFFAOYSA-N keto-phenylpyruvic acid Chemical compound OC(=O)C(=O)CC1=CC=CC=C1 BTNMPGBKDVTSJY-UHFFFAOYSA-N 0.000 description 2
- 150000002596 lactones Chemical class 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 208000022530 polyphagia Diseases 0.000 description 2
- 235000013824 polyphenols Nutrition 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- NGFFRJBGMSPDMS-UHFFFAOYSA-N psi-Taraxasterol Natural products CC12CCC(O)C(C)(C)C1CCC1(C)C2CCC2C3C(C)C(C)=CCC3(C)CCC21C NGFFRJBGMSPDMS-UHFFFAOYSA-N 0.000 description 2
- 230000001047 pyretic effect Effects 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 230000000552 rheumatic effect Effects 0.000 description 2
- 239000011435 rock Substances 0.000 description 2
- 201000010153 skin papilloma Diseases 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 150000003432 sterols Chemical class 0.000 description 2
- 235000003702 sterols Nutrition 0.000 description 2
- 230000004936 stimulating effect Effects 0.000 description 2
- 229910052712 strontium Inorganic materials 0.000 description 2
- CIOAGBVUUVVLOB-UHFFFAOYSA-N strontium atom Chemical compound [Sr] CIOAGBVUUVVLOB-UHFFFAOYSA-N 0.000 description 2
- HUTYZQWCTWWXND-NCTFTGAASA-N taraxasterol Natural products C[C@H]1[C@H]2C3=CC[C@@H]4[C@@]5(C)CC[C@H](O)C(C)(C)[C@@H]5CC[C@@]4(C)[C@]3(C)C[C@H](O)[C@@]2(C)CCC1=C HUTYZQWCTWWXND-NCTFTGAASA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- DLYUQMMRRRQYAE-UHFFFAOYSA-N tetraphosphorus decaoxide Chemical compound O1P(O2)(=O)OP3(=O)OP1(=O)OP2(=O)O3 DLYUQMMRRRQYAE-UHFFFAOYSA-N 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 239000003053 toxin Substances 0.000 description 2
- 231100000765 toxin Toxicity 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- QAIPRVGONGVQAS-DUXPYHPUSA-N trans-caffeic acid Chemical compound OC(=O)\C=C\C1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-DUXPYHPUSA-N 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 201000002498 viral encephalitis Diseases 0.000 description 2
- 239000000341 volatile oil Substances 0.000 description 2
- HRYLQFBHBWLLLL-UHFFFAOYSA-N (+)-costunolide Natural products C1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 HRYLQFBHBWLLLL-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- ACEAELOMUCBPJP-UHFFFAOYSA-N (E)-3,4,5-trihydroxycinnamic acid Natural products OC(=O)C=CC1=CC(O)=C(O)C(O)=C1 ACEAELOMUCBPJP-UHFFFAOYSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 description 1
- 239000001903 2-oxo-3-phenylpropanoic acid Substances 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- PDEJECFRCJOMEN-UHFFFAOYSA-N 4-hydroxy-3alpha,4,5,8,9,11alpha-hexahydro-6,10-dimethyl-3-methylene-cyclodeca[b]furan-2(3H)-one Natural products OC1CC(C)=CCCC(C)=CC2OC(=O)C(=C)C21 PDEJECFRCJOMEN-UHFFFAOYSA-N 0.000 description 1
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- NTDLXWMIWOECHG-UHFFFAOYSA-N 7-labden-3beta,15-diol Natural products O1CC(O)(CO)C(O)C1OC1C(O)C(O)C(CO)OC1OC(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-UHFFFAOYSA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 208000002874 Acne Vulgaris Diseases 0.000 description 1
- 241000208340 Araliaceae Species 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- MQVRGDZCYDEQML-UHFFFAOYSA-N Astragalin Natural products C1=CC(OC)=CC=C1C1=C(OC2C(C(O)C(O)C(CO)O2)O)C(=O)C2=C(O)C=C(O)C=C2O1 MQVRGDZCYDEQML-UHFFFAOYSA-N 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000219193 Brassicaceae Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 206010008631 Cholera Diseases 0.000 description 1
- 206010008909 Chronic Hepatitis Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 241000756943 Codonopsis Species 0.000 description 1
- 244000205754 Colocasia esculenta Species 0.000 description 1
- 235000006481 Colocasia esculenta Nutrition 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 241000207782 Convolvulaceae Species 0.000 description 1
- 241000125183 Crithmum maritimum Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010051244 Dyschezia Diseases 0.000 description 1
- 241000380130 Ehrharta erecta Species 0.000 description 1
- PLAPMLGJVGLZOV-UHFFFAOYSA-N Epi-orientin Natural products OC1C(O)C(O)C(CO)OC1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-UHFFFAOYSA-N 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 239000001263 FEMA 3042 Substances 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010018473 Glycosuria Diseases 0.000 description 1
- 208000008899 Habitual abortion Diseases 0.000 description 1
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 241000258196 Holothuriidae Species 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- OVSQVDMCBVZWGM-SJWGPRHPSA-N Hyperin Natural products O[C@H]1[C@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-SJWGPRHPSA-N 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- FVQOMEDMFUMIMO-UHFFFAOYSA-N Hyperosid Natural products OC1C(O)C(O)C(CO)OC1OC1C(=O)C2=C(O)C=C(O)C=C2OC1C1=CC=C(O)C(O)=C1 FVQOMEDMFUMIMO-UHFFFAOYSA-N 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 235000021353 Lignoceric acid Nutrition 0.000 description 1
- CQXMAMUUWHYSIY-UHFFFAOYSA-N Lignoceric acid Natural products CCCCCCCCCCCCCCCCCCCCCCCC(=O)OCCC1=CC=C(O)C=C1 CQXMAMUUWHYSIY-UHFFFAOYSA-N 0.000 description 1
- 241000234280 Liliaceae Species 0.000 description 1
- PTNJRKBWIYNFSY-UHFFFAOYSA-N Lirinin-O-methyl-ether Natural products COc1ccc-2c(CC3N(C)CCc4cc(OC)c(OC)c-2c34)c1 PTNJRKBWIYNFSY-UHFFFAOYSA-N 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- UPYKUZBSLRQECL-UKMVMLAPSA-N Lycopene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1C(=C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=C)CCCC2(C)C UPYKUZBSLRQECL-UKMVMLAPSA-N 0.000 description 1
- 241000721692 Lythrum Species 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 241001448624 Miliaria Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 241000218231 Moraceae Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- HIGQPQRQIQDZMP-DHZHZOJOSA-N Neryl acetate Natural products CC(C)=CCC\C(C)=C\COC(C)=O HIGQPQRQIQDZMP-DHZHZOJOSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000212324 Oenanthe <angiosperm> Species 0.000 description 1
- 229930195210 Ophiopogon Natural products 0.000 description 1
- 208000007117 Oral Ulcer Diseases 0.000 description 1
- RBVAFYCFAFADAG-UHFFFAOYSA-N Orientin Natural products OCC1OC(C(O)c2c(O)cc(O)c3C(=O)C=C(Oc23)c4ccc(O)c(O)c4)C(O)C1O RBVAFYCFAFADAG-UHFFFAOYSA-N 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- YKRGDOXKVOZESV-WRJNSLSBSA-N Paeoniflorin Chemical compound C([C@]12[C@H]3O[C@]4(O)C[C@](O3)([C@]1(C[C@@H]42)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)C)OC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-WRJNSLSBSA-N 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 241000208343 Panax Species 0.000 description 1
- 241000180649 Panax notoginseng Species 0.000 description 1
- 235000003143 Panax notoginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 208000031481 Pathologic Constriction Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 241001529246 Platymiscium Species 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 208000034189 Sclerosis Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000001203 Smallpox Diseases 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 241000529895 Stercorarius Species 0.000 description 1
- QKGJFQMGPDVOQE-UHFFFAOYSA-N Sulforaphen Natural products CS(=O)C=CCCN=C=S QKGJFQMGPDVOQE-UHFFFAOYSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 241001513369 Triosteum perfoliatum Species 0.000 description 1
- 240000000377 Tussilago farfara Species 0.000 description 1
- 235000004869 Tussilago farfara Nutrition 0.000 description 1
- 206010067584 Type 1 diabetes mellitus Diseases 0.000 description 1
- LQSNPVIQIPKOGP-UHFFFAOYSA-N UNPD159785 Natural products OC1C(O)C(O)C(CO)OC1OC1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O LQSNPVIQIPKOGP-UHFFFAOYSA-N 0.000 description 1
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 1
- 206010046788 Uterine haemorrhage Diseases 0.000 description 1
- 241000870995 Variola Species 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FSLPMRQHCOLESF-UHFFFAOYSA-N alpha-amyrenol Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C)C(C)C5C4=CCC3C21C FSLPMRQHCOLESF-UHFFFAOYSA-N 0.000 description 1
- DEDGUGJNLNLJSR-UHFFFAOYSA-N alpha-hydroxycinnamic acid Natural products OC(=O)C(O)=CC1=CC=CC=C1 DEDGUGJNLNLJSR-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- PYKYMHQGRFAEBM-UHFFFAOYSA-N anthraquinone Natural products CCC(=O)c1c(O)c2C(=O)C3C(C=CC=C3O)C(=O)c2cc1CC(=O)OC PYKYMHQGRFAEBM-UHFFFAOYSA-N 0.000 description 1
- 150000004056 anthraquinones Chemical class 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- NTDLXWMIWOECHG-YRCFQSNFSA-N apiin Chemical compound O([C@@H]1O[C@@H]([C@H]([C@H](O)[C@H]1O[C@H]1[C@@H]([C@@](O)(CO)CO1)O)O)CO)C(C=1)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(O)C=C1 NTDLXWMIWOECHG-YRCFQSNFSA-N 0.000 description 1
- NTDLXWMIWOECHG-WJAPLXOZSA-N apiin Natural products O([C@@H]1[C@@H](O)[C@H](O)[C@H](CO)O[C@H]1Oc1cc(O)c2C(=O)C=C(c3ccc(O)cc3)Oc2c1)[C@H]1[C@@H](O)[C@@](O)(CO)CO1 NTDLXWMIWOECHG-WJAPLXOZSA-N 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 230000003143 atherosclerotic effect Effects 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- JFSHUTJDVKUMTJ-QHPUVITPSA-N beta-amyrin Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C JFSHUTJDVKUMTJ-QHPUVITPSA-N 0.000 description 1
- QQFMRPIKDLHLKB-UHFFFAOYSA-N beta-amyrin Natural products CC1C2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C)CCC1(C)C QQFMRPIKDLHLKB-UHFFFAOYSA-N 0.000 description 1
- PDNLMONKODEGSE-UHFFFAOYSA-N beta-amyrin acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4(C)CCC5(C)CCC(C)(C)CC5C4=CCC23C)C1(C)C PDNLMONKODEGSE-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 235000004883 caffeic acid Nutrition 0.000 description 1
- 229940074360 caffeic acid Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 1
- 235000000431 campesterol Nutrition 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- QAIPRVGONGVQAS-UHFFFAOYSA-N cis-caffeic acid Natural products OC(=O)C=CC1=CC=C(O)C(O)=C1 QAIPRVGONGVQAS-UHFFFAOYSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- -1 coumarin, flavone Chemical class 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000013872 defecation Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000008034 disappearance Effects 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 230000001882 diuretic effect Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 206010013781 dry mouth Diseases 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- FARYTWBWLZAXNK-WAYWQWQTSA-N ethyl (z)-3-(methylamino)but-2-enoate Chemical compound CCOC(=O)\C=C(\C)NC FARYTWBWLZAXNK-WAYWQWQTSA-N 0.000 description 1
- PDEJECFRCJOMEN-OURLZOILSA-N eupatolide Chemical compound O[C@@H]1CC(/C)=C/CC\C(C)=C\[C@H]2OC(=O)C(=C)[C@@H]21 PDEJECFRCJOMEN-OURLZOILSA-N 0.000 description 1
- PDEJECFRCJOMEN-MGPQQGTHSA-N eupatolide Natural products CC1=CCCC(C)=C[C@H]2OC(=O)C(=C)[C@@H]2[C@H](O)C1 PDEJECFRCJOMEN-MGPQQGTHSA-N 0.000 description 1
- 239000003172 expectorant agent Substances 0.000 description 1
- 230000003419 expectorant effect Effects 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 208000017561 flaccidity Diseases 0.000 description 1
- 229930003944 flavone Natural products 0.000 description 1
- 235000011949 flavones Nutrition 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229920002824 gallotannin Polymers 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 229960005219 gentisic acid Drugs 0.000 description 1
- HIGQPQRQIQDZMP-UHFFFAOYSA-N geranil acetate Natural products CC(C)=CCCC(C)=CCOC(C)=O HIGQPQRQIQDZMP-UHFFFAOYSA-N 0.000 description 1
- 235000008434 ginseng Nutrition 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 210000003026 hypopharynx Anatomy 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 239000004026 insulin derivative Substances 0.000 description 1
- 230000003914 insulin secretion Effects 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- JPUKWEQWGBDDQB-QSOFNFLRSA-N kaempferol 3-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=CC(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O JPUKWEQWGBDDQB-QSOFNFLRSA-N 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000000867 larynx Anatomy 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 208000030159 metabolic disease Diseases 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- PEFNSGRTCBGNAN-UHFFFAOYSA-N nephrocizin Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C=C(C=3C=C(O)C(O)=CC=3)OC2=C1 PEFNSGRTCBGNAN-UHFFFAOYSA-N 0.000 description 1
- HIGQPQRQIQDZMP-FLIBITNWSA-N neryl acetate Chemical compound CC(C)=CCC\C(C)=C/COC(C)=O HIGQPQRQIQDZMP-FLIBITNWSA-N 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- PLAPMLGJVGLZOV-VPRICQMDSA-N orientin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1C1=C(O)C=C(O)C2=C1OC(C=1C=C(O)C(O)=CC=1)=CC2=O PLAPMLGJVGLZOV-VPRICQMDSA-N 0.000 description 1
- YKRGDOXKVOZESV-UHFFFAOYSA-N paeoniflorin Natural products O1C(C)(C2(CC34)OC5C(C(O)C(O)C(CO)O5)O)CC3(O)OC1C24COC(=O)C1=CC=CC=C1 YKRGDOXKVOZESV-UHFFFAOYSA-N 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 239000000546 pharmaceutical excipient Substances 0.000 description 1
- 150000007965 phenolic acids Chemical class 0.000 description 1
- 235000009048 phenolic acids Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- CHWRSCGUEQEHOH-UHFFFAOYSA-N potassium oxide Chemical compound [O-2].[K+].[K+] CHWRSCGUEQEHOH-UHFFFAOYSA-N 0.000 description 1
- 229910001950 potassium oxide Inorganic materials 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- OVSQVDMCBVZWGM-DTGCRPNFSA-N quercetin 3-O-beta-D-galactopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OVSQVDMCBVZWGM-DTGCRPNFSA-N 0.000 description 1
- BBFYUPYFXSSMNV-UHFFFAOYSA-N quercetin-7-o-galactoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 BBFYUPYFXSSMNV-UHFFFAOYSA-N 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- QKGJFQMGPDVOQE-HWKANZROSA-N raphanin Chemical compound CS(=O)\C=C\CCN=C=S QKGJFQMGPDVOQE-HWKANZROSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 235000012239 silicon dioxide Nutrition 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 1
- 229940032091 stigmasterol Drugs 0.000 description 1
- 235000016831 stigmasterol Nutrition 0.000 description 1
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 235000015523 tannic acid Nutrition 0.000 description 1
- 229920002258 tannic acid Polymers 0.000 description 1
- 229940033123 tannic acid Drugs 0.000 description 1
- SFEUTIOWNUGQMZ-ZHLOSDGBSA-N taraxasterol acetate Chemical compound C([C@@]12C)C[C@H](OC(C)=O)C(C)(C)[C@@H]1CC[C@]1(C)[C@@H]2CC[C@@H]2[C@H]3[C@H](C)C(=C)CC[C@]3(C)CC[C@]21C SFEUTIOWNUGQMZ-ZHLOSDGBSA-N 0.000 description 1
- BKUSDHRTBIFINS-UHFFFAOYSA-N taraxasteryl acetate Natural products CC(=O)OC1CCC2(C)C(CCC3(C)C4CCC5(C)CCC(C)(C)CC5C4(C)CCC23)C1(C)C BKUSDHRTBIFINS-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 208000004371 toothache Diseases 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 239000000304 virulence factor Substances 0.000 description 1
- 230000007923 virulence factor Effects 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- NCYCYZXNIZJOKI-UHFFFAOYSA-N vitamin A aldehyde Natural products O=CC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C NCYCYZXNIZJOKI-UHFFFAOYSA-N 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 1
- 239000002023 wood Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/616—Echinodermata, e.g. starfish, sea cucumbers or sea urchins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/31—Brassicaceae or Cruciferae (Mustard family), e.g. broccoli, cabbage or kohlrabi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/39—Convolvulaceae (Morning-glory family), e.g. bindweed
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/65—Paeoniaceae (Peony family), e.g. Chinese peony
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/89—Cyperaceae (Sedge family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Marine Sciences & Fisheries (AREA)
- Zoology (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a traditional Chinese medicine granule for treating II diabetes, which comprises the following active pharmaceutical ingredients in parts by weight: 3-9 parts of medical stone, 6-12 parts of purple lythrum herb, 12-25 parts of sticky rice, 8-16 parts of radish, 6-12 parts of ophiopogon japonicus, 5-15 parts of ligusticum wallichii, 3-7 parts of celery, 7-15 parts of fructus cannabis, 10-20 parts of panax quinquefolium, 3-9 parts of fragrant peony, 9-15 parts of semen cuscutae, 5-15 parts of herba eupatorii, 3-12 parts of water chestnut, 3-8 parts of bohadschia marmorata and 10-20 parts of radix angelicae sinensis. The traditional Chinese medicine granule not only can be used for treating II diabetes, but also can play a role in regulating blood glucose, the effect of treating the II diabetes is obvious, no side effects exist, the practicability is wide, not only can the disease be well controlled, the occurrence of heart, brain, kidney, eyes, feet and other complications can be favorably prevented, but also the restoration to the damaged organism can be achieved.
Description
Technical field
The invention belongs to traditional Chinese medicine field, especially relate to a kind of Chinese medicine granules for the treatment of type ii diabetes and preparation method thereof.
Background technology
Diabetes (diabetes) are the diseases of the easy overheap of glucose in a kind of blood, domestic to its symptom so-called " hyperglycemia ", together be called " three-hypers " with hypertension, hyperlipidemia, be by the various virulence factor such as inherited genetic factors, immunologic function disorder, infected by microbes and toxin thereof, free radical toxin, Nervous and Mental Factors act on body cause hypoinsulinism, insulin resistant etc. and cause a series of metabolism disorder syndrome such as sugar, protein, fat, water and eletrolytes.External its another name of giving is " silent killer ", and particularly " adult diabetes mellitus ", it is high especially that the middle age of more than 40 years old catches rate.
Diabetes divide the diabetes of type i diabetes, type ii diabetes, gestational diabetes and other specific types.1. I type patients with type Ⅰ DM is a kind of autoimmune disease.Autoimmune disease is because the immune system of health is attacked self making.The pancreas beta cell of immune system to self excreting insulin of diabetics is made and is attacked and kill them, and result pancreas can not secrete enough insulins.Because insulin secretion lacks, patient need rely on exogenous insulin and supplement to sustain life.
2. type ii diabetes is Adult Onset's patients with type Ⅰ DM, how the sequela of 35 ~ 40 years old, accounts for diabetics more than 90%.The ability producing insulin in patient body not completely loses, and in some patient bodies, insulin even produces too much, but the action effect of insulin is had a greatly reduced quality, and the insulin therefore in patient body is a kind of shortage relatively.3. gestational diabetes refers to the diabetes that women suffers from phenolics.Can there are diabetes at phenolics in the women of clinical data display nearly 2 ~ 3%, patient's diabetes after gestation disappear automatically.Gestational diabetes more easily occurs in obesity and lying-in woman advanced in years.Type ii diabetes may be developed into after having the gestational diabetes women of 30% nearly.The performances such as wherein type ii diabetes has very strong heritability and environmental factors, and in significant heterogeneous, and polyuria, polydipsia, polyphagia can appear in its model case, become thin, i.e. " three-many-one-little " symptom, namely so-called type ii diabetes.
In the prescription of existing treatment type ii diabetes, Authorization Notice No. CN 102772630 B(application number 201210284045.7) patent discloses a kind of medicine for the treatment of II patients with type Ⅰ DM, be crude drug mix homogeneously by the Chinese medicine of following portions by weight, be ground into 100-120 object medicated powder, add excipient, sterilization prepares tablet according to a conventional method: Radix Rehmanniae 10-14, Radix Scrophulariae 10-14, Fructus Ligustri Lucidi 10-14, Herba Epimedii 10-14, Gecko 1-4, Semen Cuscutae 3-5, Rhizoma Coptidis 3-5, Radix Panacis Quinquefolii 1-4, Ramulus Euonymi 10-14, Radix Arnebiae (Radix Lithospermi) 1-4, Radix Notoginseng 1-4, Rhizoma Polygoni Cuspidati 10-14, Fructus Gardeniae 3-5, Spica Prunellae 10-14, Radix Astragali 10-14, Rhizoma Atractylodis 10-14, Rhizoma Atractylodis Macrocephalae 10-14, Semen Plantaginis 10-14.Authorization Notice No. CN 103110815 B(application number 201310038151.1) patent discloses a kind of preparation method for the treatment of the Chinese medicine composition of type Ⅱdiabetes mellitus, it is characterized in that, take off the crude drug stating weight proportion: Radix Astragali 10-30 part, Radix Codonopsis 9-30 part, Radix Rehmanniae 12-30 part, Rhizoma Dioscoreae 15-30 part, Rhizoma Polygonati Odorati 6-12 part, Fructus Lycii 5-15 part, Radix Asparagi 10-20 part, Radix Scrophulariae 10-15 part, Fructus Ligustri Lucidi 6-15 part, Radix Puerariae 7-15 part, Fructus Momordicae charantiae powder 20-50 part, Radix Linderae 3-9 part, Fructus Mori 9-15 part, Cortex Lycii 15-30 part
As can be seen here, Chinese medicine achieves good curative effect in treatment type ii diabetes, but its preparation method all more complicated, and great majority are decoctions, and as everyone knows, decoction is inconvenient to carry, and pure Chinese medicine decoction hardship very, are not easy to swallow.
Summary of the invention
For the deficiency of existing treatment type ii diabetes method, an object of the present invention is to provide a kind of Chinese medicine granules for the treatment of type ii diabetes, taking in this medicine therapeutic process, instant effect, and have no side effect, while improving polydipsia, polyuria symptom, can also regulate blood glucose, be a kind of ideal Chinese medicine granule for the treatment of type ii diabetes.
Another object of the present invention is just to provide the preparation method of the Chinese medicine granules of above-mentioned treatment type ii diabetes.
Above-mentioned purpose of the present invention is achieved through the following technical solutions:
Treat a Chinese medicine granules for type ii diabetes, each crude drug is as follows, is weight portion: Maifanitum 3-9, Herba Lythri Salicariae 6-12, Oryza glutinosa 12-25, Radix Raphani 8-16, Radix Ophiopogonis 6-12, Rhizoma Chuanxiong 5-15, Herba Apii graveolentis 3-7, Fructus Cannabis 7-15, Radix Panacis Quinquefolii 10-20, Radix Paeoniae 3-9, Semen Cuscutae 9-15, Herba Eupatorii 5-15, Corm Eleocharitis 3-12, Bai Nican 3-8, Radix Angelicae Sinensis 10-20.
Treat a Chinese medicine granules for type ii diabetes, preferred scheme, each crude drug is as follows, be weight portion: Maifanitum 5-7, Herba Lythri Salicariae 8-10, Oryza glutinosa 16-21, Radix Raphani 12-14, Radix Ophiopogonis 8-10, Rhizoma Chuanxiong 8-13, Herba Apii graveolentis 4-6, Fructus Cannabis 10-12, Radix Panacis Quinquefolii 13-18, Radix Paeoniae 5-7, Semen Cuscutae 11-13, Herba Eupatorii 8-13, Corm Eleocharitis 5-10, Bai Nican 4-6, Radix Angelicae Sinensis 13-18.
Treat a Chinese medicine granules for type ii diabetes, better preferred scheme, each crude drug is as follows, be weight portion: Maifanitum 6, Herba Lythri Salicariae 9, Oryza glutinosa 18, Radix Raphani 13, Radix Ophiopogonis 9, Rhizoma Chuanxiong 10, Herba Apii graveolentis 5, Fructus Cannabis 11, Radix Panacis Quinquefolii 15, Radix Paeoniae 6, Semen Cuscutae 12, Herba Eupatorii 11, Corm Eleocharitis 8, Bai Nican 5, Radix Angelicae Sinensis 15.
Treat a preparation method for the Chinese medicine granules of type ii diabetes, step is as follows:
1. Maifanitum is placed in the hot water of 80-100 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 10-30 minute (preferably 20 minutes), taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 1-5 minute, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts in the hot pot that dryouies and fries 3-8 minute with low baking temperature, take out, and when placing room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 10-30 minute slowly, dries in the air coolly to grind to form smalls, crosses 80-120 mesh sieve (preferably 100 mesh sieves);
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 1-3 centimetre after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 1-3 time, add Oryza glutinosa weight 8-12 water doubly, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 4-8 minute, be blended into cold water, turn slow fire boiling 20-40 minute, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste at 50-70 DEG C of dry 10-18 hour, make granule.
The preparation method of above-mentioned Chinese medicine granules, step 1. Maifanitum is placed in the hot water (preferred Maifanitum is placed in the hot water of 90 DEG C) of 85-95 DEG C.
The preparation method of above-mentioned Chinese medicine granules, step 2. high temperature sterilization 2-4 minute (preferred high temperature sterilization 3 minutes).
The preparation method of above-mentioned Chinese medicine granules, step 3. little fire is dried 15-25 minute (preferred little fire dries 20 minutes slowly) slowly.
The preparation method of above-mentioned Chinese medicine granules, 5. step adds Oryza glutinosa weight 9-11 water (preferably adding the water of Oryza glutinosa weight 10 times) doubly.
The preparation method of above-mentioned Chinese medicine granules, step after 5. big fire boils 5-7 minute, is blended into cold water, turns slow fire boiling 25-35 minute (preferred big fire boil 6 minutes after, be blended into cold water, turn slow fire boiling 30 minutes).
The preparation method of above-mentioned Chinese medicine granules, step 6. thick paste, at 55-65 DEG C of dry 12-16 hour, makes granule (preferred thick paste, 60 DEG C of dryings 14 hours, makes granule).
The present invention is to the Be very effective of type ii diabetes, and be the therapeutic effect making the present invention reach best, every day 3 times, take respectively at half an hour after breakfast, lunch and dinner, each 2g, boiled water is taken after mixing it with water, and within 10 days, is a course for the treatment of.
The pharmacological effect of each crude drug is respectively:
Maifanitum: base is former: be Acid-intermediate igneous rock rocks beschtauite.Composition: Maifanitum main component has silicon dioxide, aluminium oxide, ferrum oxide, ferrous oxide, magnesium oxide, calcium oxide, sodium oxide, potassium oxide, titanium dioxide, phosphorus pentoxide, manganese oxide, carbon dioxide, and the trace element such as fluorine, sulfur, strontium, barium, copper, zinc.The property of medicine: " detailed outline ": " sweet, temperature, nontoxic." function cures mainly: removing toxic substances and promoting granulation, damp eliminating spleen invigorating.Cure mainly carbuncle carbuncle on the back, acne, eczema, beriberi, miliaria, finger is chapped, chloasma, toothache, oral ulcer, rheumatic arthralgia, lumbago and backache, chronic hepatitis, gastritis, dysentery, diabetes, neurasthenia, wound is red and swollen, hypertension, senile sclerosis of blood vessels, tumor, lithangiuria.Generally make health product.
Herba Lythri Salicariae: have another name called Purple Loosestrife, Herba pteridis vittatae, to tooth grass, be the herb of Lythraceae Lythrum plant Herba Lythri Salicariae.The property of medicine: bitter in the mouth, cold in nature.Composition: herb contains Salicarin, choline, gallotannin, orientin, chlorogenic acid etc.Find according to modern pharmacological research, this medical instrument has blood sugar lowering, antibacterial, heat-clearing and toxic substances removing, anastaltic effect, and for hyperglycemia, spit blood, epistaxis, has loose bowels, and skin infection festers.
Oryza glutinosa: base is former: be the kernel that shells of grass family oryza plant Oryza sativa L. var. glutinosa Matsum..The property of medicine: sweet, temperature.Return spleen, stomach, lung meridian.Function cures mainly: invigorating the spleen and replenishing QI, invigorating the spleen to arrest diarrhea, reducing urination, arresting sweating, removing toxic substances.Cure mainly Deficiency and coldness of spleen and stomach to have loose bowels, cholera is told inverse, frequent micturition of quenching one's thirst, spontaneous perspiration, variola, hemorrhoid.
Radix Raphani: base is former: be fresh of Cruciferae Radix Raphani platymiscium Radix Raphani.Composition: root contains glycoside glucosinolate, glucose raphanin, raphanusin.Phenolic acids: P-coumaric acid, caffeic acid, ferulic acid, phenylpyruvic acid, gentisic acid etc.The property of medicine: acrid, sweet, cool; Ripe person is sweet, flat.Return spleen, stomach, lung, large intestine channel.Function cures mainly: help digestion, and the therapeutic method to keep the adverse QI flowing downwards is reduced phlegm, hemostasis.Cure mainly dyspepsia, food stagnation distension, acid regurgitation, regurgitation of food from the stomach, tells food, and hemorrhoidal hamorrhage is had loose bowels, dysentery, constipation, phlegm-heat cough, discomfort in the throat, hemoptysis, and spit blood, epistaxis, has blood in stool, and quenches one's thirst, and drenches worm.Outer treatment skin ulcer abscess, damage congestive edema, scalds and chilblain.
Radix Ophiopogonis: Radix Ophiopogonis (Ophiopogon japonicus) has another name called dwarf lilyturf, book band grass, Radix Ophiopogonis, Radix Ophiopogonis is Liliaceae Ophiopogon perennial evergreen herbaceous plant.Fibrous root is more sturdy, and the top of root or middle part are often expanded becomes fusiform meat fritter.Be used as medicine with tuber.Sweet, micro-hardship, is slightly cold.GUIXIN, lung, stomach warp., micro-hardship, is slightly cold.GUIXIN, lung, stomach warp.[function with cure mainly] YIN nourishing and the production of body fluid promoting, lung moistening clears away heart-fire.For dryness of the lung dry cough, deficiency of YIN consumptive disease is coughed, sore throat pharyngalgia, and Tianjin wound is thirsty, and interior-heat is quenched one's thirst, vexed insomnia, dryness of the intestine constipation.
Herba Apii graveolentis: Herba Apii graveolentis, belongs to samphire.Have Herba Oenanthes Javanicae, Herba Apii graveolentis, Herba Apii graveolentis three kinds, function is close, and medicinal is good with Herba Apii graveolentis.Herba Apii graveolentis fragrance is denseer, claims " medicine celery ".But with Herba Coriandri is not a kind, Herba Apii graveolentis rich in proteins, carbohydrate, carotene, vitamin B group, calcium, phosphorus, ferrum, sodium etc., simultaneously, have and have calming liver and clearing heat, expelling wind and removing dampness, relieving restlessness is subsided a swelling, cooling blood for hemostasis, removing toxic substances lung qi dispersing, stomach invigorating profit blood, bowel relieving is convenient, nourishing the lung to arrest cough, reduce blood pressure, effect of brain-strengthening calmness.Apiin also containing active ingredient in base of leaf, majudin and volatile oil, have blood pressure lowering, blood fat reducing, the atherosclerotic effect of control; Also certain auxiliary dietary function is had to neurasthenia, menoxenia, gout, anti-muscle spasm; It can also promote gastric secretion, increases appetite.Particularly old people, easily suffers from because body movement amount is little, dietary amount is few, amount of drinking water is not enough and being hard and dry, and often has some Herba Apii graveolentis and can be beneficial to defecation by stimulating gastrointestinal wriggling.
Fructus Cannabis: base is former: be the kernel of Moraceae Cannabis plant Fructus Cannabis.Composition: seed contains trigonelline, L-dextrorotation isoleucine Glycocoll betaine.Seed fatty acids and lipid: stearic acid, arachidic acid, lignoceric acid, Palmic acid, palmitoleic acid etc.The property of medicine: sweet, flat.Return spleen, stomach, large intestine channel.Function cures mainly: moisturize laxation, and diuretic is invigorated blood circulation.Cure mainly dryness of the intestine constipation, migratory arthralgia, quench one's thirst, edema due to wind pathogen, beriberi, pyretic stranguria, dysentery, menoxenia, skin ulcer tinea, erysipelas.
Radix Panacis Quinquefolii: Radix Panacis Quinquefolii is Araliaceae Panax perennial grass wood plant, another name Radix Panacis Quinquefolii, Radix Panacis Quinquefolii, Western Radix Ginseng, cool in nature, sweet in the mouth, micro-hardship.Boosting qi and nourishing yin, clearing away heat and promoting production of body fluid.Lose for deficiency of vital energy the moon, interior-heat, cough with asthma expectorant blood, deficiency-heat is tired of tired, quenches one's thirst, and dry mouth larynx is done.Consumption 3 ~ 6g.Lung benefiting is cloudy, clear asthenic fire, promoting the production of body fluid to quench thirst.Control deficiency of the lung chronic cough, lose blood, dry throat and mouth, deficiency-heat is tired of tired.
Radix Paeoniae: the fresh and crisp succulence of root of Radix Paeoniae, can hyoscine (be used as medicine time-division Radix Paeoniae Rubra, the Radix Paeoniae Alba two kinds).According to analysis, Peony Root contains paeoniflorin and benzoic acid, and purposes is different because of kind.The traditional Chinese medical science is thought: the Radix Paeoniae Alba in Chinese medicine mainly refers to the root of Radix Paeoniae, and it has spasmolytic, eases pain, the effect of stimulating the menstrual flow.Effective to diseases such as the stomachache of women, stomach spasm, dizzy, gout, diuresis.
Herba Eupatorii: base is former: be the aerial parts of Compositae feverwort Herba Eupatorii.Composition: 1. Herba Eupatorii herb is containing volatile oil: to P-cymene, neryl acetate, thymol methyl ether.Taraxasterol is contained, taraxasterylacetate, taraxasterol cetylate etc. in flower and leaf.2. Taiwan Herba Eupatorii is containing sesquiterpenoids composition: eupatolide, Herba Euptatorii formosani lactone, 4-hydroxyl-2-methylol-2-butylene acyl Herba Euptatorii formosani lactone.The property of medicine: pungent, flat.Return spleen, stomach warp.Function cures mainly: expelling summer-heat and damp, be amusing and in.Cure mainly heat-damp in summer or hygropyrexia from the beginning of, generate heat nose heave, abdominal distention uncomfortable in chest, gastral cavity painful abdominal mass is not hungry, nausea and vomiting, sweet greasy in mouth, quenches one's thirst.
Corm Eleocharitis: another name Horse hoof, black taro, Di Li.Flavor efficacy: sweet, cold.Function heat clearing away, reduce phlegm, removing food stagnancy, change wart.Be applicable to that epidemic febrile disease is quenched one's thirst, jaundice, pyretic stranguria, mass in the abdomen, conjunctival congestion, laryngopharynx swelling and pain, wart etc.Prevention acute infectious disease, clearing away heat-fire, removing pathogenic heat from blood and toxic substance from the body, diuresis relieving constipation is eliminated the phlegm, help digestion de-swelling, conditioning hemorrhoid or dysentery is had blood in stool, woman uterine bleeding, lung-dryness syndrome due to deficiency of YIN, phlegm-heat cough, discomfort in the throat, mass in the abdomen are gathered, conjunctival congestion is hidden from view, auxiliary effect such as to bring down a fever.In addition, Corm Eleocharitis contains a kind of antiviral substance can suppress epidemic encephalitis, influenza virus, can be used for the propagation preventing epidemic encephalitis and influenza.
Bai Nican: for Holothuriidae Bu Shi joins the entirety belonging to animal Bohadschia argus Jaeger and figure stricture of vagina Bai Nican (removing internal organs).The property of medicine: taste is micro-sweet, warm in nature.Composition: main containing triterpene glycosides, also has the elements such as sodium, potassium, calcium, phosphorus, magnesium, ferrum, zinc.Find according to modern pharmacological research, this medical instrument has effect of sterilization, nourishing YIN to lower pathogenic fire, the kidney invigorating, for diseases such as edema.
Semen Cuscutae: base is former: be the herb of Convolvulaceae Hellweed Semen Cuscutae.Composition: Semen Cuscutae is containing alkaloid, anthraquinone, coumarin, flavone, glycoside, sterol, tannic acid, saccharide etc.Flavonoid has: Quercetin, astragalin, hyperin; Sterols has: cholesterol, campesterol, cupreol, stigmasterol, β-Amyrin.Also trace element is contained as strontium, molybdenum, calcium, magnesium, ferrum, manganese, zinc, copper etc. and several amino acids (free amino acid in seed and the total amino acids after being hydrolyzed are 5.3%, and wherein the content of essential amino acids accounts for 42.8%).The property of medicine: micro-pungent, sweet, flat, nontoxic.Function cures mainly: the kidney invigorating and essence nourishing, nourishing the liver to improve visual acuity.The waist knee joint muscles and bones being applicable to deficiency of the liver and kindey is ached, the diseases such as legs and feet weakness, impotence and seminal emission, crazy talk, frequent micturition, dripping urination, dizziness and blurred vision, blurring of vision, Hiccough and deaf and women's leukorrhagia, habitual abortion.
Rhizoma Chuanxiong: activating QI to alleviate the depression, method wind-dryness is wet, promoting blood circulation and stopping pain.Controlling air-cooled headache revolves dizzy, and hypochondriac pain abdomen aches, arthralgia due to cold clonic spasm of the muscle, amenorrhea, difficult labour, postpartum stagnation block pain, ulcer sores.For menoxenia, amenorrhea dysmenorrhea, abdominal mass is suffered from abdominal pain, the twinge of the breast side of body, tumbling and swelling, headache, rheumatic arthralgia.
Radix Angelicae Sinensis: sweet, pungent, warm, enriches blood; Invigorate blood circulation; Menstruction regulating and pain relieving; Moisturize laxation.The all cards of main blood deficiency; Menoxenia; Amenorrhea; Dysmenorrhea; Lump in the abdomen knot is poly-; Metrorrhagia; Asthenia cold abdominalgia; Flaccidity syndrome and arthralgia syndrome; Numbness of the skin; Dryness of the intestine dyschezia; Heavy after bloody dysentery; Ulcer sores; Injury from falling down.
Chinese medicine granules of the present invention can not only treat type ii diabetes shape, the effect regulating blood glucose can also be played, treatment type ii diabetes Be very effective, have no side effect, practicality is wide, the state of an illness not only can be made to be well controlled, to be conducive to the generation preventing many-sided complication such as the heart, brain, kidney, eye, foot, and repair can be played to the body of damage.
Detailed description of the invention
Describe technical scheme of the present invention in detail below in conjunction with embodiment and experimental example, but protection domain is not by this restriction.
embodiment 1: a kind of Chinese medicine granules for the treatment of type ii diabetes, each crude drug is as follows, is weight portion (getting 10g for every part): Maifanitum 3, Herba Lythri Salicariae 6, Oryza glutinosa 12, Radix Raphani 8, Radix Ophiopogonis 6, Rhizoma Chuanxiong 5, Herba Apii graveolentis 3, Fructus Cannabis 7, Radix Panacis Quinquefolii 10, Radix Paeoniae 3, Semen Cuscutae 9, Herba Eupatorii 5, Corm Eleocharitis 3, Bai Nican 3, Radix Angelicae Sinensis 10.
Treat a Chinese medicine granules for type ii diabetes, preparation process is as follows:
1. Maifanitum is placed in the hot water of 80 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 10 minutes, taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 1 minute, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts interior the low baking temperature of hot pot dryouied and fry 3 minutes, takes out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 10 minutes slowly, dries in the air coolly to grind to form smalls, crosses 80 mesh sieves;
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 1 centimetre after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 1 time, add the water of Oryza glutinosa weight 8 times, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 4 minutes, be blended into cold water, turn slow fire boiling 20 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 50 DEG C of dryings 10 hours, make granule.
model case one:king XX, female, 45 years old, people from Liaocheng of Shandong Province.Symptom: patient suffers from type ii diabetes, the symptom of have polydipsia, polyuria, polyphagia, becoming thin, has a meal a lot every day, and health although do not have pain, but made the huge mental pressure of patient's back not as one day in one day.Drinking YUQUAN WAN during one's sickness, but effect is not fine always, in nearest half a year, eats YUQUAN WAN and does not substantially have onset, malaise symptoms aggravates, and household asks about everywhere, learns Chinese medicine granules of the present invention always.
Take embodiment 1 gained Chinese medicine granules, take 5 days, sensation appetite reduces to some extent, polyuria, and polydipsia symptom alleviates; Take 15 days, appetite recovers normal substantially, and polydipsia symptom is alleviated further; Take 15 days, polydipsia transference cure, appetite recovers normal, and patient has laid down psychological burden, and the mental status of people might as well be a lot.
embodiment 2: a kind of Chinese medicine granules for the treatment of type ii diabetes, each crude drug is as follows, is weight portion (getting 10g for every part): Maifanitum 9, Herba Lythri Salicariae 12, Oryza glutinosa 25, Radix Raphani 16, Radix Ophiopogonis 12, Rhizoma Chuanxiong 15, Herba Apii graveolentis 7, Fructus Cannabis 15, Radix Panacis Quinquefolii 20, Radix Paeoniae 9, Semen Cuscutae 15, Herba Eupatorii 15, Corm Eleocharitis 12, Bai Nican 8, Radix Angelicae Sinensis 20.
Treat a Chinese medicine granules for type ii diabetes, preparation process is as follows:
1. Maifanitum is placed in the hot water of 100 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 30 minutes, taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 5 minutes, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts interior the low baking temperature of hot pot dryouied and fry 8 minutes, takes out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 30 minutes slowly, dries in the air coolly to grind to form smalls, crosses 120 mesh sieves;
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 1-3 centimetre after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 3 times, add the water of Oryza glutinosa weight 12 times, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 8 minutes, be blended into cold water, turn slow fire boiling 40 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 70 DEG C of dryings 18 hours, make granule.
model case two:zhu XX, man, 58 years old, Donga County, Liaocheng of Shandong Province.Symptom: patient suffers from type ii diabetes, eats four meals every day, still often has hunger sensation, although have an enormous appetite, but lean body mass, drink large water gaging every day and can not alleviate thirsty symptom.On ordinary days brew diabetic tea, effect is undesirable, removes examination in hospital, and doctor advised takes gained Chinese medicine granules of the present invention.
Take embodiment 2 gained Chinese medicine granules, take 5 days, thirsty symptom alleviates; Take 15 days, blood glucose is steady, and patient has stopped the blood sugar lowering Western medicine always taken; Take 20 days, thirsty symptom disappears substantially, and patient's appetite also recovers normal, and body weight also increases to some extent; Take 40 days, take period, patient blood glucose is held stationary always, still adheres to so far taking for keeping blood glucose.
embodiment 3:treat a Chinese medicine granules for type ii diabetes, each crude drug is as follows, is weight portion (getting 10g for every part): Maifanitum 5, Herba Lythri Salicariae 8, Oryza glutinosa 16, Radix Raphani 12, Radix Ophiopogonis 8, Rhizoma Chuanxiong 8, Herba Apii graveolentis 4, Fructus Cannabis 10, Radix Panacis Quinquefolii 13, Radix Paeoniae 5, Semen Cuscutae 11, Herba Eupatorii 8, Corm Eleocharitis 5, Bai Nican 4, Radix Angelicae Sinensis 13.
Treat a Chinese medicine granules for type ii diabetes, preparation process is as follows:
1. Maifanitum is placed in the hot water of 85 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 15 minutes, taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 2 minutes, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts interior the low baking temperature of hot pot dryouied and fry 5 minutes, takes out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 15 minutes slowly, dries in the air coolly to grind to form smalls, crosses 90 mesh sieves;
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 1.5 centimetres after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 1 time, add the water of Oryza glutinosa weight 9 times, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 5 minutes, be blended into cold water, turn slow fire boiling 25 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 55 DEG C of dryings 12 hours, make granule.
embodiment 4:treat a Chinese medicine granules for type ii diabetes, each crude drug is as follows, is weight portion (getting 10g for every part): Maifanitum 7, Herba Lythri Salicariae 10, Oryza glutinosa 21, Radix Raphani 14, Radix Ophiopogonis 10, Rhizoma Chuanxiong 13, Herba Apii graveolentis 6, Fructus Cannabis 12, Radix Panacis Quinquefolii 18, Radix Paeoniae 7, Semen Cuscutae 13, Herba Eupatorii 13, Corm Eleocharitis 10, Bai Nican 6, Radix Angelicae Sinensis 18.
Treat a Chinese medicine granules for type ii diabetes, preparation process is as follows:
1. Maifanitum is placed in the hot water of 95 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 25 minutes, taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 4 minutes, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts interior the low baking temperature of hot pot dryouied and fry 7 minutes, takes out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 25 minutes slowly, dries in the air coolly to grind to form smalls, crosses 110 mesh sieves;
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 2.5 centimetres after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 3 times, add the water of Oryza glutinosa weight 11 times, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 7 minutes, be blended into cold water, turn slow fire boiling 35 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 65 DEG C of dryings 16 hours, make granule.
model case three:poplar XX, man, 50 years old, people from Jiyang County, Jinan City, Shandong Province.Symptom: patient suffers from II type glycosuria, often feel thirsty, drink a large amount of water every day and still can not alleviate thirsty symptom, number of times of going to toilet every day reaches 20 times, although there is no slight illness, life is brought inconvenience, take other drug and be all of no curative effect, household is very worried, finds gained Chinese medicine granules of the present invention online being not intended to.
Take embodiment 4 gained Chinese medicine granules, take 3 days, thirsty symptom is alleviated to some extent, no longer occurs the sensation of very dry cough after drinking water in a large number; Take 8 days, blood glucose declines, and every day drinks discharge reduction, and number of times of going to toilet decreases many, substantially remains on every day 10 times; Take 30 days, thirsty transference cure, total urination time recovers normal, and blood glucose can held stationary.Have no side effect during taking appearance.
embodiment 5: a kind of Chinese medicine granules for the treatment of type ii diabetes, each crude drug is as follows, is weight portion (getting 10g for every part): Maifanitum 6, Herba Lythri Salicariae 9, Oryza glutinosa 18, Radix Raphani 13, Radix Ophiopogonis 9, Rhizoma Chuanxiong 10, Herba Apii graveolentis 5, Fructus Cannabis 11, Radix Panacis Quinquefolii 15, Radix Paeoniae 6, Semen Cuscutae 12, Herba Eupatorii 11, Corm Eleocharitis 8, Bai Nican 5, Radix Angelicae Sinensis 15.
Treat a Chinese medicine granules for type ii diabetes, preparation process is as follows:
1. Maifanitum is placed in the hot water of 90 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 20 minutes, taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 3 minutes, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts interior the low baking temperature of hot pot dryouied and fry 6 minutes, takes out, and during placement room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 20 minutes slowly, dries in the air coolly to grind to form smalls, crosses 100 mesh sieves;
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 2 centimetres after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 2 times, add the water of Oryza glutinosa weight 10 times, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 6 minutes, be blended into cold water, turn slow fire boiling 30 minutes, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste 60 DEG C of dryings 14 hours, make granule.
test example 1the clinical practice of the Chinese medicine granules of embodiment 5 gained treatment type ii diabetes: screen 200 routine patients in 4 hospitals, wherein women 100 example, male 100 example.Before test 1 week, carry out Continuous Observation to this crowd, record symptom and change, be divided into two groups at random, experimental group and matched group, experimental group takes products obtained therefrom of the present invention, and matched group takes the medicine (as conventional medicines such as YUQUAN WAN) of other treatment type ii diabetes.Curative effect situation criterion: cure: after taking this product, malaise symptoms disappears completely; Effective: after taking this product, malaise symptoms alleviates or partial disappearance; Invalid: after taking this product, malaise symptoms is unchanged or recur.Total effectively comprising cures with effective, and result is as shown in table 1.
The checking of embodiment 5 products obtained therefrom therapeutic effect taken by table 1
Therapeutic effect: as apparent from table 1 can, take healing 88 example (88%) of experimental group of the Chinese medicine granules of the embodiment of the present invention 3 gained treatment type ii diabetes, effective 11 examples (11%), invalid 1 example (1%), total effective rate 99%.And the cure rate of matched group only reaches 45%, inefficiency is but up to 32%, and the experimental group taking the Chinese medicine granules of gained of the present invention treatment type ii diabetes is obviously better than taking the matched group of other drug.Chinese medicine granules of the present invention can not only treat the diabetes caused by diabetes, can also regulate blood glucose in the lump, alleviates the body burden of patient, is a kind of ideal Chinese medicine granule for the treatment of type ii diabetes.
Claims (10)
1. treat a Chinese medicine granules for type ii diabetes, it is characterized in that: each crude drug is as follows, is weight portion: Maifanitum 3-9, Herba Lythri Salicariae 6-12, Oryza glutinosa 12-25, Radix Raphani 8-16, Radix Ophiopogonis 6-12, Rhizoma Chuanxiong 5-15, Herba Apii graveolentis 3-7, Fructus Cannabis 7-15, Radix Panacis Quinquefolii 10-20, Radix Paeoniae 3-9, Semen Cuscutae 9-15, Herba Eupatorii 5-15, Corm Eleocharitis 3-12, Bai Nican 3-8, Radix Angelicae Sinensis 10-20.
2. the Chinese medicine granules for the treatment of type ii diabetes according to claim 1, is characterized in that: each crude drug is as follows, is weight portion: Maifanitum 5-7, Herba Lythri Salicariae 8-10, Oryza glutinosa 16-21, Radix Raphani 12-14, Radix Ophiopogonis 8-10, Rhizoma Chuanxiong 8-13, Herba Apii graveolentis 4-6, Fructus Cannabis 10-12, Radix Panacis Quinquefolii 13-18, Radix Paeoniae 5-7, Semen Cuscutae 11-13, Herba Eupatorii 8-13, Corm Eleocharitis 5-10, Bai Nican 4-6, Radix Angelicae Sinensis 13-18.
3. the Chinese medicine granules for the treatment of type ii diabetes according to claim 1, is characterized in that: each crude drug is as follows, is weight portion: Maifanitum 6, Herba Lythri Salicariae 9, Oryza glutinosa 18, Radix Raphani 13, Radix Ophiopogonis 9, Rhizoma Chuanxiong 10, Herba Apii graveolentis 5, Fructus Cannabis 11, Radix Panacis Quinquefolii 15, Radix Paeoniae 6, Semen Cuscutae 12, Herba Eupatorii 11, Corm Eleocharitis 8, Bai Nican 5, Radix Angelicae Sinensis 15.
4. the preparation method of the Chinese medicine granules of the treatment type ii diabetes according to any one of claim 1-3, is characterized in that: step is as follows:
1. Maifanitum is placed in the hot water of 80-100 DEG C, when water temperature is cooled to room temperature, adds Sal, after Sal melts completely, soak 10-30 minute (preferably 20 minutes), taking-up is placed on clean gauze stand-by;
2. get Radix Angelicae Sinensis and Rhizoma Chuanxiong to clean, drain away the water, high temperature sterilization 1-5 minute, section, uses rice vinegar uniform spraying, slightly vexed 10 minutes, puts in the hot pot that dryouies and fries 3-8 minute with low baking temperature, take out, and when placing room temperature, it is stand-by to grind to form smalls;
3. be placed on tile by Herba Lythri Salicariae, Radix Ophiopogonis, Fructus Cannabis, Radix Panacis Quinquefolii, Radix Paeoniae, Semen Cuscutae, Herba Eupatorii, Corm Eleocharitis and Bai Nican, little fire dries 10-30 minute slowly, dries in the air coolly to grind to form smalls, crosses 80-120 mesh sieve (preferably 100 mesh sieves);
4. cleaned by Radix Raphani, the block being cut into coin-size and the Herba Apii graveolentis being cut into long 1-3 centimetre after cleaning mix stand-by;
5. Oryza glutinosa is eluriated 1-3 time, add Oryza glutinosa weight 8-12 water doubly, soak after 1 hour and add step 1. gained Maifanitum, big fire adds step 4. gains after boiling, after big fire boils 4-8 minute, be blended into cold water, turn slow fire boiling 20-40 minute, slowly stir with ferrum spoon, to be mixed when becoming thick liquid to Radix Raphani and Herba Apii graveolentis, Maifanitum is taken out, adds step 2. and 3. gained smalls, fully stir into thick paste;
6. by step 5. gained thick paste at 50-70 DEG C of dry 10-18 hour, make granule.
5. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: step 1. Maifanitum is placed in the hot water (preferred Maifanitum is placed in the hot water of 90 DEG C) of 85-95 DEG C.
6. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: step 2. high temperature sterilization 2-4 minute (preferred high temperature sterilization 3 minutes).
7. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: step 3. little fire is dried 15-25 minute (preferred little fire dries 20 minutes slowly) slowly.
8. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: 5. step adds Oryza glutinosa weight 9-11 water (preferably adding the water of Oryza glutinosa weight 10 times) doubly.
9. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: step after 5. big fire boils 5-7 minute, is blended into cold water, turns slow fire boiling 25-35 minute (preferred big fire boil 6 minutes after, be blended into cold water, turn slow fire boiling 30 minutes).
10. the preparation method of Chinese medicine granules according to claim 4, is characterized in that: step 6. thick paste, at 55-65 DEG C of dry 12-16 hour, makes granule (preferred thick paste, 60 DEG C of dryings 14 hours, makes granule).
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410772168.4A CN104491529A (en) | 2014-12-16 | 2014-12-16 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410772168.4A CN104491529A (en) | 2014-12-16 | 2014-12-16 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104491529A true CN104491529A (en) | 2015-04-08 |
Family
ID=52933043
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410772168.4A Pending CN104491529A (en) | 2014-12-16 | 2014-12-16 | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104491529A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105748981A (en) * | 2016-02-29 | 2016-07-13 | 鹿宁 | Combined medicine for treating diabetic nephropathy and preparation method thereof |
| CN105878796A (en) * | 2015-08-17 | 2016-08-24 | 张斌 | Vinegar beverage capable of treating type-II diabetes mellitus complicated with dyslipidemia and preparation method of vinegar beverage |
| CN106822652A (en) * | 2017-03-24 | 2017-06-13 | 成都海青生物科技有限公司 | It is a kind of to treat decoction medicine of diabetes and preparation method thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1164413A (en) * | 1997-04-25 | 1997-11-12 | 苏新发 | Chinese patent drug for treatment of diabetes mellitus |
| CN1506079A (en) * | 2002-12-06 | 2004-06-23 | 路晓钦 | Diabetes treating medicine |
| CN104082672A (en) * | 2014-07-09 | 2014-10-08 | 朱路英 | Health-preserving porridge with hypoglycemic effect and preparation method thereof |
-
2014
- 2014-12-16 CN CN201410772168.4A patent/CN104491529A/en active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1164413A (en) * | 1997-04-25 | 1997-11-12 | 苏新发 | Chinese patent drug for treatment of diabetes mellitus |
| CN1506079A (en) * | 2002-12-06 | 2004-06-23 | 路晓钦 | Diabetes treating medicine |
| CN104082672A (en) * | 2014-07-09 | 2014-10-08 | 朱路英 | Health-preserving porridge with hypoglycemic effect and preparation method thereof |
Non-Patent Citations (2)
| Title |
|---|
| 田建华编著: "《糖尿病医疗全书》", 31 March 2007 * |
| 田洪江编著: "《健胃养生宜忌》", 31 May 2007 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN105878796A (en) * | 2015-08-17 | 2016-08-24 | 张斌 | Vinegar beverage capable of treating type-II diabetes mellitus complicated with dyslipidemia and preparation method of vinegar beverage |
| CN105748981A (en) * | 2016-02-29 | 2016-07-13 | 鹿宁 | Combined medicine for treating diabetic nephropathy and preparation method thereof |
| CN106822652A (en) * | 2017-03-24 | 2017-06-13 | 成都海青生物科技有限公司 | It is a kind of to treat decoction medicine of diabetes and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103860969A (en) | Traditional Chinese medicine for increasing weight | |
| CN104069390A (en) | Traditional Chinese medicine decoction for putting on weight | |
| CN104491529A (en) | Traditional Chinese medicine granule for treating II diabetes and preparation method thereof | |
| CN108576341A (en) | A kind of coffee and preparation method improving male's sexual | |
| CN101164600A (en) | Medicine for treating acne and whelk | |
| CN104491531A (en) | Traditional Chinese medicine granule for treating consumptive thirst caused by diabetes and preparation method of traditional Chinese medicine granule | |
| CN105232987A (en) | Traditional Chinese medicine promoting neurosurgery postoperative rehabilitation | |
| CN105079676A (en) | Medicine for treating fatty liver and preparing method of medicine | |
| CN105288273A (en) | Formula for treating nephrotic syndrome and preparation method | |
| CN104888081A (en) | Instant herbal medicine for treating kidney-yang deficiency type diarrhea associated with menstruation | |
| CN104706976A (en) | Traditional Chinese medicine preparation capable of benefiting qi for tranquillization to treatinsomnia and preparation method of traditional Chinese medicine preparation | |
| CN104524494A (en) | Traditional Chinese medicine composition | |
| CN105435131A (en) | Traditional Chinese medicine composition for treating chronic heart failure and preparation method thereof | |
| CN104623374A (en) | Traditional Chinese medicine preparation for treating acute radiation sickness and preparation method of traditional Chinese medicine preparation | |
| CN104689067A (en) | Traditional Chinese medicine composition for treating sexual precocity and application thereof | |
| CN104800780A (en) | Traditional Chinese medicine preparation for treating polycystic ovarian syndrome and preparation method of traditional Chinese medicine preparation | |
| CN104524270A (en) | Pills for relieving renal dysfunction caused by diabetes mellitus and preparation method thereof | |
| CN105233093A (en) | Traditional Chinese medicine tablet for treating gastroptosis | |
| CN105434934A (en) | Traditional Chinese medicine pill used for treating gynaecology climacteric syndrome, and preparation method thereof | |
| CN106266427A (en) | A kind of Traditional Chinese medicinal liquor treating nephropathy and preparation method thereof | |
| CN104940777A (en) | Electuary capable of treating liver-yang hyperactivity and spleen weakness type diarrhea during menstruation and preparation method thereof | |
| CN105267815A (en) | Spray for treating infant lung-kidney-deficiency type asthma and preparing method thereof | |
| CN104547959A (en) | Traditional Chinese medicine composition for treating hyperlipidemia and preparation method thereof | |
| CN105288166A (en) | Traditional Chinese medicine composition for thyroid enlargement and preparation method thereof | |
| CN105381409A (en) | Medicine for treating cholelithiasis and preparation method of medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150408 |